CA19-9 Benefits Prognostication of Pancreatic Cancer: Is It Time to Add CA19-9 to Its Staging Criteria?-Reference-Cited by-同舟云学术

CA19-9 Benefits Prognostication of Pancreatic Cancer: Is It Time to Add CA19-9 to Its Staging Criteria?

Published:2024-05-06 Issue:8 Volume:31 Page:4839-4840
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Gao Xiang,In Haejin

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15321-w.pdf

Reference7 articles.

1. National Comprehensive Cancer Network. Pancreatic adenocarcinoma (Version 1.2024—December 13, 2023). https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. [Accessed February 25, 2024].

2. Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1):2–11.

3. Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H. Survival analysis in patients with pancreatic ductal adenocarcinoma undergoing chemoradiotherapy followed by surgery according to the international consensus on the 2017 definition of borderline resectable cancer. Cancers (Basel). 2018;10(3):65.

4. Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer. HPB (Oxford). 2019;21(9):1211–8.

5. Schouten TJ, van Goor IWJM, Dorland GA, et al. The value of biological and conditional factors for staging of patients with resectable pancreatic cancer undergoing upfront resection: a nationwide analysis. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15070-w.